DocGo Appoints Dr. Stephen K. Klasko as Independent Chair of the Board
Key Highlights Dr. Stephen Klasko joins DocGo as independent Chair of the Board, effective October 1, 2024. Dr. Klasko’s leadership spans healthcare, education,…
Day: October 4, 2024
10 posts
Reimagine Care and Moffitt Cancer Center Partner to Transform Cancer Care Delivery
Key Highlights Reimagine Care to provide 24/7 on-demand cancer care services for Moffitt patients. Moffitt Cancer Center is the only NCI-designated…
Lyra Health Expands Support for Substance Use Disorder
Key Highlights Comprehensive support for cannabis, stimulants, opioids, and nicotine now available nationwide. Lyra Renew offers evidence-based treatments for a…
LetsGetChecked Finalizes Acquisition of Truepill, Expanding Digital Pharmacy Capabilities
Key Highlights LetsGetChecked acquires Truepill, enhancing digital pharmacy capabilities. Combines health testing and treatment services for a seamless patient experience.…
Halda Therapeutics Appoints Christian Schade as CEO, Signaling Next Stage of Growth
Key Highlights Halda Therapeutics names Christian Schade as President and CEO. Schade brings over 20 years of biotech…
Luxa Biotechnology Appoints Dr. Keith Dionne as CEO to Lead Advanced RPESC Therapy Development
Key Highlights Dr. Keith Dionne appointed as CEO of Luxa Biotechnology. Luxa develops a novel RPESC therapy for…
VedaBio Appoints Dr. Randy Rasmussen to its Board of Directors
Key Highlights Dr. Randy Rasmussen, former CEO of BioFire Diagnostics, joins VedaBio’s Board of Directors. Brings over 30 years…
Nym Secures $47M Growth Investment to Expand Autonomous Medical Coding
Key Highlights Nym secures $47 million in growth funding led by PSG. Participants include Google Ventures, Addition, and…
Resilience Appoints Dr. Susan Billings as Chief Commercial Officer
Key Highlights Dr. Susan Billings joins Resilience as Chief Commercial Officer. Brings 15+ years of leadership in commercial strategy and biotech…
Phreesia Renews Contract with CMS Innovation Center Through 2029
Key Highlights Phreesia’s contract with CMS Innovation Center extended through 2029. PAM performance measure used in CMS’s alternative payment models. Supports Kidney…